Literature DB >> 14752169

Osteoarthritis--the impact of a serious disease.

F C Breedveld1.   

Abstract

Osteoarthritis (OA) is common in the elderly, but also affects younger people. The disease symptoms are debilitating and, as well as causing physical impairment, can affect the psychosocial wellbeing of the patient. Furthermore, the impact of this disease is substantially increased by the common occurrence of comorbid conditions, such as hypertension and renal impairment. Non-steroidal anti-inflammatory drugs are commonly used to treat the symptoms of OA, but their related gastrointestinal side-effects increase the impact of this disease. Gastrointestinal tolerability should therefore be considered in the design of new therapies that reduce the symptoms and activity of OA. Furthermore, because this disease is associated with comorbid conditions, patient safety must also be considered when designing new therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752169     DOI: 10.1093/rheumatology/keh102

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  32 in total

1.  Localized hyperthermia induced by microwave diathermy in osteoarthritis of the knee: a randomized placebo-controlled double-blind clinical trial.

Authors:  Arrigo Giombini; Annalisa Di Cesare; Mariachiara Di Cesare; Maurizio Ripani; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-15       Impact factor: 4.342

2.  Changes in in vivo knee loading with a variable-stiffness intervention shoe correlate with changes in the knee adduction moment.

Authors:  Jennifer C Erhart; Chris O Dyrby; Darryl D D'Lima; Clifford W Colwell; Thomas P Andriacchi
Journal:  J Orthop Res       Date:  2010-12       Impact factor: 3.494

3.  Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.

Authors:  Wen-Nan Huang; Tim K Tso
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

4.  Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.

Authors:  J Y Reginster; K Malmstrom; A Mehta; G Bergman; A T Ko; S P Curtis; A S Reicin
Journal:  Ann Rheum Dis       Date:  2006-12-01       Impact factor: 19.103

5.  Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.

Authors:  Marc Afilalo; Mila S Etropolski; Brigitte Kuperwasser; Kathy Kelly; Akiko Okamoto; Ilse Van Hove; Achim Steup; Bernd Lange; Christine Rauschkolb; Juergen Haeussler
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  Prevalence and associated factors of knee osteoarthritis in a community-based population in Heilongjiang, Northeast China.

Authors:  Liying Jiang; Jiesheng Rong; Qiuju Zhang; Fulan Hu; Shide Zhang; Xia Li; Yashuang Zhao; Tianzun Tao
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

7.  Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis.

Authors:  Miriam G Cisternas; Edward Yelin; Jeffrey N Katz; Daniel H Solomon; Elizabeth A Wright; Elena Losina
Journal:  Arthritis Rheum       Date:  2009-12-15

8.  A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis.

Authors:  C Thorne; A D Beaulieu; D J Callaghan; W F O'Mahony; J M Bartlett; R Knight; G R Kraag; R Akhras; P S Piraino; J Eisenhoffer; Z Harsanyi; A C Darke
Journal:  Pain Res Manag       Date:  2008 Mar-Apr       Impact factor: 3.037

9.  Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997.

Authors:  Edward Yelin; Louise Murphy; Miriam G Cisternas; Aimee J Foreman; David J Pasta; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2007-05

10.  Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?

Authors:  Peter R Kornaat; Ruby Sharma; Rob J van der Geest; Hildo J Lamb; Margreet Kloppenburg; Marie-Pierre Hellio le Graverand; Johan L Bloem; Iain Watt
Journal:  Skeletal Radiol       Date:  2009-07-03       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.